Effect of Clarithromycin, a Strong CYP3A and P-glycoprotein Inhibitor, on the Pharmacokinetics of Edoxaban in Healthy Volunteers and the Evaluation of the Drug Interaction with Other Oral Factor Xa Inhibitors by a Microdose Cocktail Approach.
Alexander LenardSimon A HermannFelicitas StollJuergen BurhenneKathrin I FoersterGerd MikusAndreas D MeidWalter E HaefeliAntje BlankPublished in: Cardiovascular drugs and therapy (2023)
EudraCT Number: 2018-002490-22.